157 results on '"Lansang, Perla"'
Search Results
2. Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate‐to‐severe atopic dermatitis treated with dupilumab
3. Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate‐to‐severe atopic dermatitis treated with dupilumab.
4. Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective
5. Brodalumab-Induced Eczematous Reactions in Psoriasis Patients: Management With Switching to Risankizumab
6. Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review
7. Use of risankizumab in two HIV-positive patients with psoriasis
8. Figure S1 - Supplemental material for Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review
9. Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review
10. Management of moderate‐to‐severe plaque psoriasis with biologics: A treat‐to‐target position paper
11. Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study
12. Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study
13. 53838 Real-world drug survival of risankizumab at a tertiary care psoriasis clinic in Toronto, Canada.
14. Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors
15. Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study
16. The Utility of IL-17 Inhibitors in Neutrophilic Dermatoses: A Systematic Review
17. 26291 Rapid skin improvement with ixekizumab treatment for pediatric patients with psoriasis: Results from IXORA-peds
18. Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
19. Table S2 - Supplemental material for The Utility of IL-17 Inhibitors in Neutrophilic Dermatoses: A Systematic Review
20. Figure S1 - Supplemental material for The Utility of IL-17 Inhibitors in Neutrophilic Dermatoses: A Systematic Review
21. 42307 Matching-adjusted indirect comparison of efficacy of ixekizumab versus secukinumab through 1 year in pediatric patients with severe plaque psoriasis
22. Durable Remission of Pemphigus With a Fixed-Dose Rituximab Protocol
23. Oral Methotrexate Monotherapy for Severe Alopecia Areata: A Single Center Retrospective Case Series
24. Supplementary Material 1 - Supplemental material for Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
25. Supplementary Material 1 - Supplemental material for Skin Damage Prevention Strategies During COVID-19: Assessing Their Effect on N95 Mask Seal Integrity
26. Supplementary Material 2 - Supplemental material for Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
27. Topical imiquimod in the treatment of infantile hemangiomas: A retrospective study
28. Population pharmacokinetic and exposure–efficacy analysis of ixekizumab in paediatric patients with moderate‐to‐severe plaque psoriasis (IXORA‐PEDS).
29. Skin Damage Prevention Strategies During COVID-19: Assessing Their Effect on N95 Mask Seal Integrity
30. Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
31. Management of pediatric plaque psoriasis using biologics
32. Approach to the Assessment and Management of Pediatric Patients with Atopic Dermatitis: A Consensus Document. Section II: Comorbid Disease in Pediatric Atopic Dermatitis
33. Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section IV: Consensus Statements on the Assessment and Management of Pediatric Atopic Dermatitis
34. Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section III: Treatment Options for Pediatric Atopic Dermatitis
35. Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section I: Overview of Pediatric Atopic Dermatitis
36. Generalized granuloma annulare treated with mycophenolate mofetil.
37. Hong_article_section_V__803625 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
38. 1329_Section_0_Supplementary_Appendix_A_19Jul18 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
39. JCMS_Gooderham_803627 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
40. JCMS_Gooderham_803628 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section II: Tools for Assessing the Severity of Atopic Dermatitis
41. 1329_Section_V_Supplementary_Table_1 – Supplemental material for Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
42. Undergraduate Dermatology Medical Education: Results of a Large-Scale Patient Viewing Program
43. Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis
44. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
45. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
46. Qu’est-ce que l’hidradénite suppurée?
47. Eosinophils in the skin—a red herring masking lymphoma: a case series
48. Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report.
49. Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study.
50. Erratum for “Treatment of Childhood Psoriasis with Phototherapy and Photochemotherapy”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.